Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy.
暂无分享,去创建一个
[1] P. Knoke. Poster Abstracts , 2012, International Journal of Obesity.
[2] K. Moriello,et al. Recommendations for the management and treatment of dermatophytosis in animal shelters. , 2006, The Veterinary clinics of North America. Small animal practice.
[3] J. Roujeau,et al. Terbinafine-Induced Subacute Cutaneous Lupus Erythematosus , 2005, Dermatology.
[4] K. Moriello. Treatment of dermatophytosis in dogs and cats: review of published studies. , 2004, Veterinary dermatology.
[5] N. Ryder,et al. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. , 2002, Medical mycology.
[6] T. Kotnik. Drug efficacy of terbinafine hydrochloride (Lamisil) during oral treatment of cats, experimentally infected with Microsporum canis. , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.
[7] M. Drobnič-Košorok,et al. Determination of terbinafine hydrochloride in cat hair by two chromatographic methods. , 2001, Biomedical chromatography : BMC.
[8] M. Drobnič-Košorok,et al. Terbinafine hydrochloride treatment of Microsporum canis experimentally-induced ringworm in cats. , 2001, Veterinary microbiology.
[9] L. Castañón-Olivares,et al. Effectiveness of terbinafine in the eradication of Microsporum canis from laboratory cats , 2001, Mycoses.
[10] D. Melamed,et al. Determination of terbinafine (Lamisil) in human hair by microbore liquid chromatography/tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.
[11] T. Kotnik. Treatment with terbinafine of experimentally infected cats with M. canis: tolerability and side effects of the drug. , 2000 .
[12] F. Pedonese,et al. Efficacy of Oral Terbinafine in Feline Dermatophytosis Due to Microsporum Canis , 1999, Journal of feline medicine and surgery.
[13] P. Kass,et al. Determination of skin concentrations of enrofloxacin in dogs with pyoderma. , 1998, American journal of veterinary research.
[14] Lynde,et al. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature , 1998, The British journal of dermatology.
[15] J. Kovarik,et al. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites , 1995, Antimicrobial agents and chemotherapy.
[16] L. Millérioux,et al. Levels of terbinafine in plasma, stratum corneum, dermis–epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days , 1994, Clinical and experimental dermatology.
[17] D. Faulds,et al. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. , 1992, Drugs.
[18] E. Breitschwerdt,et al. Bone marrow hypoplasia in a cat treated with griseofulvin. , 1991, Journal of the American Veterinary Medical Association.
[19] T. Jones,et al. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. , 1991, Acta dermato-venereologica.